Document is current
Any future updates will be listed below
-
Authors
Vohryzek, Jakub https://orcid.org/0000-0003-0994-5054
Luppi, Andrea I.
Atasoy, Selen
Deco, Gustavo https://orcid.org/0000-0002-8995-7583
Carhart-Harris, Robin L.
Timmermann, Christopher https://orcid.org/0000-0002-2281-377X
Kringelbach, Morten L. https://orcid.org/0000-0002-3908-6898
- License Information
-
More Information
Article History
Received: 24 February 2025
Revised: 9 July 2025
Accepted: 28 July 2025
First Online: 12 September 2025
Competing interests
: RC-H reports receiving consulting fees from COMPASS Pathways, Entheon Biomedical, Mydecine, Synthesis Institute, Tryp Therapeutics, and Usona Institute. All other authors report no conflict of interest.
